medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 6

<< Back Next >>

Rev Invest Clin 2014; 66 (6)

Is effective a shortened surveillance system of bloodstream infection?

Macías JH, Arvizu MG, Luna MA, Godínez SI, Macías AE, ÁlvarezJA
Full text How to cite this article

Language: Spanish
References: 20
Page: 490-494
PDF size: 137.56 Kb.


Key words:

Infection control, Catheter-related infections, Vascular access devices.

ABSTRACT

Introduction. Surveillance is necessary for bloodstream infection control. Daily monitoring of the central venous catheter (CVC) use, a time-demanding process, is the standard denominator to calculate the infection rate; surveillance of only one day per week has been proposed as alternative. Objective. To determine whether surveillance of one day per week is similar to daily monitoring in a second-level hospital. Material and methods. Daily monitoring of CVC utilization ratio was done during nine weeks in four locations of a second-level hospital. For each day, proportional differences respect to the global CVC utilization ratio was estimated. An ANOVA test was done to find differences between each weekday. Results. CVC usage surveillance was performed for 9 weeks, so nine determinations were obtained for each weekday. No significant differences were found between each day (F = 2.20, p = 0.056). The lowest sampling discrepancy was found on Wednesdays. Conclusions. According to previous studies, and our own data, monitoring the CVC use one day per week is a reasonable alternative to the daily surveillance.


REFERENCES

  1. World Health Organization (WHO). Report on the burden of endemic health care-associated infection worldwide, clean care is safer care. Geneva, Switzerland: WHO; 2011.

  2. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán y Secretaría de Salud. Medición de la prevalencia de infecciones nosocomiales en hospitales generales de las principales instituciones públicas de salud; informe documental en extenso. Julio 2013. Disponible en: http://www.dged.salud.gob.mx/contenidos/ dess/descargas/NOSOCOM_EXT.pdf. Acceso el 18/07/13.

  3. Stone PW, Pogorzelska M, Kunches L, Hirschhorn LR. Hospital staffing and health care-associated infections: a systematic review of the literature. Clin Infect Dis 2008; 47(7): 937-44.

  4. El-Kholy A, Saied T, Gaber M, et al. Device-associated nosocomial infection rates in intensive care units al Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country. Am J Infect Control 2012; 40(6): e216-e220.

  5. Bonnal C, Mourvillier B, Bronchard R, et al. Prospective assessment of hospital-acquired bloodstream infections: how many may be preventable? Qual Saf Health Care 2010; 19: e30. Doi 10.1136/qshc.2008.030296

  6. Macias AE, Muñoz JM, Herrera LE, Medina H, Hernández I, Alcántar D, Ponce de León S. Nosocomial pediatric bacteremia: the role of intravenous set contamination in developing countries. Infect Control Hosp Epidemiol 2004; 25(3): 226-30.

  7. Pujol M, Limón E. Epidemiología general de las infecciones nosocomiales. Sistemas y programas de vigilancia. Enferm Infecc Microbiol Clin 2013; 31(2): 108-13.

  8. Singh S, Kumar RK, Sundaram KR, Kanijilal B, Nair P. Improving outcomes and reducing costs by modular training in infection control in a resource-limited setting. Int J Qual Health Care 2012; 24(6): 641-8.

  9. Haley RW, Culver DH, White JW, et al. The efficacy of infeccition surveillance and control programs in preventing nosocomial infectios in US hospital. Am J Epidemiol 1985; 121(2): 182-205.

  10. Heipel D, Ober JD, Edmond MB, Bearman GML. Surgical site infection surveillance for neurosurgical procedures: a comparison of passive surveillance by surgeons to active surveillance by infection control professionals. Am J Infect Control 2007; 35(3): 200-02.

  11. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011; 24(1): 141-73.

  12. Tsan L, Hojlo C, Kearns MA, et al. Infection surveillance and control programs in the Department of Veterans Affairs nursing home care: a preliminary assessment. Am J Infect Control 2006; 34: 80-3.

  13. O’Boyle C, Jackson M, Henly SJ. Staffing requirements for infection control programs in US health facilities: Delphi project. Am J Infect Control 2002; 30(6): 321-33.

  14. NHSN National Healthcare safety network (NHSN) overview. Marzo 2013. Disponible en: http://www.cdc.gov/nhsn/pdfs/pscmanual/ 1PSC_OverviewCurrent.pdf. Acceso el 20/03/2013.

  15. Dudeck M, Horan TC, Peterson KD, et al. National Healthcare safety network (NHSN) repor, data summary for 2010, deviceassociated module. Am J Infect Control 2011; 39(5): 798-816.

  16. Thompson ND, Edwards JR, Bamberg W, et al. Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Health Care Safety Network surveillance methods. Infect Control Hosp Epidemiol 2013; 34(3): 221-8.

  17. Shelly MA, Concannon C, Dumyati G. Device use ratio measured weekly can reliably estimate central line-days for central line-associated bloodstream infection rates. Infect Control Hosp Epidemiol 2011; 32(7): 727-30.

  18. Klevens RM, Tokars JI, Edwards J, Horan T, National Nosocomial Infections Surveillance System. Sampling for collection of central line-days denominators in surveillance of healthcareassociated bloodstream infections. Infect Control Hosp Epidemiol 2006; 27(4): 338-42.

  19. Perla RJ, Peden CJ, Goldmann D, Lloyd R. Health care-associated infection reporting: the need for ongoing reliability and validity assessment. Am J Infect Control 2009; 37(8): 615-8.

  20. Lin MY, Hota B, Khan YM. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010; 304(18): 2035-41.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2014;66